{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:49:27Z","timestamp":1785124167810,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012505","name":"Royal Perth Hospital Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.abb.2021.109032","type":"journal-article","created":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T19:11:53Z","timestamp":1631387513000},"page":"109032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"711","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-4952","authenticated-orcid":false,"given":"Jose","family":"Caparros-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"O'Gara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-9229","authenticated-orcid":false,"given":"Trevor A.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6042-437X","authenticated-orcid":false,"given":"Natalie C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2021.109032_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.abb.2021.109032_bib2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.abb.2021.109032_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: the diagnosis and management","volume":"7","author":"Abd El-Kader","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.abb.2021.109032_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.abb.2021.109032_bib5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.abb.2021.109032_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.abb.2021.109032_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1756283X09359964","article-title":"Treatment options for nonalcoholic fatty liver disease","volume":"3","author":"Lam","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.abb.2021.109032_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14218\/JCTH.2017.00056","article-title":"Future pharmacotherapy for non-alcoholic steatohepatitis (NASH): review of phase 2 and 3 trials","volume":"6","author":"Connolly","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.abb.2021.109032_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-019-00020-1","article-title":"New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis","volume":"72","author":"Pydyn","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.abb.2021.109032_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.abb.2021.109032_bib11","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/ALN.0b013e3181fcf3cc","article-title":"Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive Care","volume":"113","author":"Weitzberg","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.abb.2021.109032_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21010\/ajtcam.v14i3.4","article-title":"Nitrate IN leafy green vegetables and estimated intake","volume":"14","author":"Brki\u0107","year":"2017","journal-title":"Afr. J. Tradit., Complementary Altern. Med."},{"key":"10.1016\/j.abb.2021.109032_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ajcn\/nqy108","article-title":"Assessment of dietary nitrate intake in humans: a systematic review","volume":"108","author":"Babateen","year":"2018","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.abb.2021.109032_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.redox.2015.05.004","article-title":"Effects of long-term dietary nitrate supplementation in mice","volume":"5","author":"Hezel","year":"2015","journal-title":"Redox Biology"},{"key":"10.1016\/j.abb.2021.109032_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2016.07.025","article-title":"Dietary nitrate improves age-related hypertension and metabolic abnormalities in rats via modulation of angiotensin II receptor signaling and inhibition of superoxide generation","volume":"99","author":"Hezel","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.abb.2021.109032_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cmet.2011.01.004","article-title":"Dietary inorganic nitrate improves mitochondrial efficiency in humans","volume":"13","author":"Larsen","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.abb.2021.109032_bib17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00125-017-4259-6","article-title":"Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice","volume":"60","author":"Kina-Tanada","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.abb.2021.109032_bib18","doi-asserted-by":"crossref","first-page":"17716","DOI":"10.1073\/pnas.1008872107","article-title":"Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice","volume":"107","author":"Carlstrom","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2021.109032_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.1809406115","article-title":"AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis","volume":"116","author":"Cordero-Herrera","year":"2019","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.abb.2021.109032_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2012.12.002","article-title":"An improved mass spectrometry-based measurement of NO metabolites in biological fluids","volume":"56","author":"Yang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.abb.2021.109032_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2021.109032_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.abb.2021.109032_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-7592-1_17","article-title":"GC-MS analysis of short-chain fatty acids in feces, cecum content, and blood samples","volume":"1730","author":"Hoving","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.abb.2021.109032_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.niox.2020.01.006","article-title":"Mechanisms of the protective effects of nitrate and nitrite in cardiovascular and metabolic diseases","volume":"96","author":"Liu","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.abb.2021.109032_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.abb.2021.109032_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.abb.2021.109032_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1758-5996-5-29","article-title":"The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding","volume":"5","author":"Henriksen","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.abb.2021.109032_bib28","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-specific activation of AMPK prevents steatosis on a high-fructose diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.abb.2021.109032_bib29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc 1 and Acc 2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.abb.2021.109032_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/2211-5463.12221","article-title":"AMP-activated protein kinase regulates lipid metabolism and the fibrotic phenotype of hepatic stellate cells through inhibition of autophagy","volume":"7","author":"Chen","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.abb.2021.109032_bib31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3892\/ijo.2016.3627","article-title":"AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages","volume":"49","author":"Lee","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.abb.2021.109032_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.abb.2021.109032_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1053\/jhep.2001.22702","article-title":"Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition","volume":"33","author":"Yerushalmi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.abb.2021.109032_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3164\/jcbn.13-46","article-title":"The involvement of endoplasmic reticulum stress in bile acid-induced hepatocellular injury","volume":"54","author":"Adachi","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.abb.2021.109032_bib35","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.abb.2021.109032_bib36","article-title":"Dysregulation of Bile Acids in Patients with NAFLD","author":"Zhang","year":"2018"},{"key":"10.1016\/j.abb.2021.109032_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.abb.2021.109032_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.abb.2021.109032_bib39","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.abb.2021.109032_bib40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2008.01.004","article-title":"Balancing cholesterol synthesis and absorption in the gastrointestinal tract","volume":"2","author":"Cohen","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.abb.2021.109032_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.abb.2021.109032_bib42","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.abb.2021.109032_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The bile acid membrane receptor TGR5: a valuable metabolic target","volume":"29","author":"Pols","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.abb.2021.109032_bib44","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbalip.2019.05.016","article-title":"Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats","volume":"1864","author":"Tang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.abb.2021.109032_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cvr\/cvm016","article-title":"FXR-mediated regulation of eNOS expression in vascular endothelial cells","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.abb.2021.109032_bib46","first-page":"367","article-title":"Farnesoid X receptor regulates vascular reactivity through nitric oxide mechanism","volume":"63","author":"Zhang","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.abb.2021.109032_bib47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.abb.2021.109032_bib48","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.abb.2021.109032_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.freeradbiomed.2019.12.002","article-title":"Nitrate ameliorates dextran sodium sulfate-induced colitis by regulating the homeostasis of the intestinal microbiota","volume":"152","author":"Hu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.abb.2021.109032_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001255","article-title":"Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity","volume":"8","author":"Ma","year":"2020","journal-title":"BMJ Open Diabetes Research & Care"},{"key":"10.1016\/j.abb.2021.109032_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for Health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv Nutr"},{"key":"10.1016\/j.abb.2021.109032_bib52","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3389\/fphar.2020.01247","article-title":"Farnesoid X receptor agonists as therapeutic target for cardiometabolic diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.abb.2021.109032_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/bjc.2011.37","article-title":"Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion","volume":"104","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.abb.2021.109032_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.12.006","article-title":"Effects of taurocholic acid on immunoregulation in mice","volume":"15","author":"Wang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.abb.2021.109032_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2334\/josnusd.19-0342","article-title":"Taurocholic acid lowers the inflammatory response of gingival fibroblasts, epithelial cells, and macrophages","volume":"62","author":"Talebian","year":"2020","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.abb.2021.109032_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.freeradbiomed.2016.08.009","article-title":"Low dose nitrate improves endothelial dysfunction and plaque stability in the ApoE-\/- mouse fed a high fat diet","volume":"99","author":"Bakker","year":"2016","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.abb.2021.109032_bib57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/ars.2013.5481","article-title":"Cross-talk between nitrate-nitrite-NO and NO synthase pathways in control of vascular homestasis","volume":"23","author":"Carlstrom","year":"2015","journal-title":"Antix Redox Signal"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121002812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121002812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:20:58Z","timestamp":1757744458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986121002812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S0003986121002812"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2021.109032","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2021.109032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109032"}}